<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">lvrach</journal-id><journal-title-group><journal-title xml:lang="ru">Лечащий Врач</journal-title><trans-title-group xml:lang="en"><trans-title>Lechaschi Vrach</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-5175</issn><issn pub-type="epub">2687-1181</issn><publisher><publisher-name>ООО «Издательство "Открытые системы"»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">lvrach-552</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Хроническая индуцированная крапивница: алгоритм лечения</article-title><trans-title-group xml:lang="en"><trans-title>Chronic inducible urticaria: treatment algorithm</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Скандер</surname><given-names>Д. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Skander</surname><given-names>D. M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алленова</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Allenova</surname><given-names>A. S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колхир</surname><given-names>П. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolkhir</surname><given-names>P. V.</given-names></name></name-alternatives><email xlink:type="simple">pavel.kolkhir@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>ФГАОУ ВО Первый МГМУ им. И. М. Сеченова МЗ РФ</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>23</day><month>06</month><year>2021</year></pub-date><volume>0</volume><issue>7</issue><fpage>68</fpage><lpage>68</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Скандер Д.М., Алленова А.С., Колхир П.В., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Скандер Д.М., Алленова А.С., Колхир П.В.</copyright-holder><copyright-holder xml:lang="en">Skander D.M., Allenova A.S., Kolkhir P.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.lvrach.ru/jour/article/view/552">https://journal.lvrach.ru/jour/article/view/552</self-uri><abstract><p>Хроническая индуцированная крапивница (ХИНК) — заболевание кожи, характеризующееся появлением рецидивирующих волдырей и/или ангиоотеков в результате действия различных специфических факторов. В обзоре рассматривается ступенчатый алгоритм, применяемый для лечения ХИНК и предлагаемый в недавно пересмотренном международном согласительном документе EAACI/GA?LEN/EDF/WAO.</p></abstract><trans-abstract xml:lang="en"><p>Chronic inducible urticaria (CindU) is a prevalent skin disease characterized by the appearance of recurrent wheals, angioedema or both, as a response to specific and reproducible triggers. Here, we discuss the recently revised EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and treatment of urticaria and review available therapeutic options for CindU. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>Актуальная тема</kwd><kwd>Обзор литературы</kwd><kwd>Хроническая индуцированная крапивница</kwd><kwd>Лечение</kwd><kwd>Антигистаминные препараты</kwd><kwd>Омализумаб</kwd><kwd>Циклоспорин А</kwd><kwd>Индукция толерантности</kwd></kwd-group><kwd-group xml:lang="en"><kwd>review</kwd><kwd>chronic inducible urticaria</kwd><kwd>treatment</kwd><kwd>antihistamines</kwd><kwd>omalizumab</kwd><kwd>cyclosporine A</kwd><kwd>induction of tolerance</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Zuberbier T. et al. The EAACI/GA (2)LEN/EDF/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. The 2017 Revision and Update // Allergy. 2018.</mixed-citation><mixed-citation xml:lang="en">Zuberbier T. et al. The EAACI/GA (2)LEN/EDF/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. The 2017 Revision and Update // Allergy. 2018.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Magerl M. et al. The definition, diagnostic testing, and management of chronic inducible urticarias — The EAACI/GA (2) LEN/EDF/UNEV consensus recommendations 2016 update and revision // Allergy. 2016. 71 (6): p. 780–802.</mixed-citation><mixed-citation xml:lang="en">Magerl M. et al. The definition, diagnostic testing, and management of chronic inducible urticarias — The EAACI/GA (2) LEN/EDF/UNEV consensus recommendations 2016 update and revision // Allergy. 2016. 71 (6): p. 780–802.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Dressler C. et al. Chronic inducible urticaria: a systematic review of treatment options // J Allergy Clin Immunol. 2018.</mixed-citation><mixed-citation xml:lang="en">Dressler C. et al. Chronic inducible urticaria: a systematic review of treatment options // J Allergy Clin Immunol. 2018.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Maurer M. et al. Unmet clinical needs in chronic spontaneous urticaria. A GA (2)LEN task force report // Allergy. 2011. 66 (3): p. 317–330.</mixed-citation><mixed-citation xml:lang="en">Maurer M. et al. Unmet clinical needs in chronic spontaneous urticaria. A GA (2)LEN task force report // Allergy. 2011. 66 (3): p. 317–330.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Trevisonno J. et al. Physical urticaria: Review on classification, triggers and management with special focus on prevalence including a meta-analysis // Postgrad Med. 2015. 127 (6): p. 565–570.</mixed-citation><mixed-citation xml:lang="en">Trevisonno J. et al. Physical urticaria: Review on classification, triggers and management with special focus on prevalence including a meta-analysis // Postgrad Med. 2015. 127 (6): p. 565–570.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Silpa-archa N., Kulthanan K., Pinkaew S. Physical urticaria: prevalence, type and natural course in a tropical country // J Eur Acad Dermatol Venereol. 2011. 25 (10): p. 1194–1199.</mixed-citation><mixed-citation xml:lang="en">Silpa-archa N., Kulthanan K., Pinkaew S. Physical urticaria: prevalence, type and natural course in a tropical country // J Eur Acad Dermatol Venereol. 2011. 25 (10): p. 1194–1199.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Bernstein J. A. et al. The diagnosis and management of acute and chronic urticaria: 2014 update // J Allergy Clin Immunol. 2014. 133 (5): p. 1270–1277.</mixed-citation><mixed-citation xml:lang="en">Bernstein J. A. et al. The diagnosis and management of acute and chronic urticaria: 2014 update // J Allergy Clin Immunol. 2014. 133 (5): p. 1270–1277.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kocaturk E. et al. Management of chronic inducible urticaria according to the guidelines: A prospective controlled study // J Dermatol Sci. 2017. 87 (1): p. 60–69.</mixed-citation><mixed-citation xml:lang="en">Kocaturk E. et al. Management of chronic inducible urticaria according to the guidelines: A prospective controlled study // J Dermatol Sci. 2017. 87 (1): p. 60–69.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Staevska M. et al. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria // J Allergy Clin Immunol. 2010. 125 (3): p. 676–682.</mixed-citation><mixed-citation xml:lang="en">Staevska M. et al. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria // J Allergy Clin Immunol. 2010. 125 (3): p. 676–682.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Chang T. W. et al. The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria // J Allergy Clin Immunol. 2015. 135 (2): p. 337–342.</mixed-citation><mixed-citation xml:lang="en">Chang T. W. et al. The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria // J Allergy Clin Immunol. 2015. 135 (2): p. 337–342.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Maurer M. et al. Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence // J Allergy Clin Immunol. 2018. 141 (2): p. 638–649.</mixed-citation><mixed-citation xml:lang="en">Maurer M. et al. Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence // J Allergy Clin Immunol. 2018. 141 (2): p. 638–649.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Hurabielle C. et al. No major effect of cyclosporin A in patients with severe solar urticaria: a french retrospective case series // Acta Derm Venereol. 2015. 95 (8): p. 1030–1031.</mixed-citation><mixed-citation xml:lang="en">Hurabielle C. et al. No major effect of cyclosporin A in patients with severe solar urticaria: a french retrospective case series // Acta Derm Venereol. 2015. 95 (8): p. 1030–1031.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Toda S. et al. Six cases of antihistamine-resistant dermographic urticaria treated with oral ciclosporin // Allergol Int. 2011. 60 (4): p. 547–550.</mixed-citation><mixed-citation xml:lang="en">Toda S. et al. Six cases of antihistamine-resistant dermographic urticaria treated with oral ciclosporin // Allergol Int. 2011. 60 (4): p. 547–550.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Seth S., Khan D. A. The Comparative Safety of Multiple Alternative Agents in Refractory Chronic Urticaria Patients // J Allergy Clin Immunol Pract. 2017. 5 (1): p. 165–170 e2.</mixed-citation><mixed-citation xml:lang="en">Seth S., Khan D. A. The Comparative Safety of Multiple Alternative Agents in Refractory Chronic Urticaria Patients // J Allergy Clin Immunol Pract. 2017. 5 (1): p. 165–170 e2.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Vestergaard C. et al. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion // Eur J Dermatol. 2017. 27 (1): p. 10–19.</mixed-citation><mixed-citation xml:lang="en">Vestergaard C. et al. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion // Eur J Dermatol. 2017. 27 (1): p. 10–19.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Zuberbier T. et al. The EAACI/GA (2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update // Allergy. 2014. 69 (7): p. 868–887.</mixed-citation><mixed-citation xml:lang="en">Zuberbier T. et al. The EAACI/GA (2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update // Allergy. 2014. 69 (7): p. 868–887.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Leenutaphong V. et al. Plasmapheresis in solar urticaria. Dermatologica, 1991. 182 (1): p. 35–8.</mixed-citation><mixed-citation xml:lang="en">Leenutaphong V. et al. Plasmapheresis in solar urticaria. Dermatologica, 1991. 182 (1): p. 35–8.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Aubin, F. et al., Severe and refractory solar urticaria treated with intravenous immunoglobulins: a phase II multicenter study // J Am Acad Dermatol. 2014. 71 (5): p. 948–953 e1.</mixed-citation><mixed-citation xml:lang="en">Aubin, F. et al., Severe and refractory solar urticaria treated with intravenous immunoglobulins: a phase II multicenter study // J Am Acad Dermatol. 2014. 71 (5): p. 948–953 e1.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ramsay C. A. Solar urticaria treatment by inducing tolerance to artificial radiation and natural light // Arch Dermatol. 1977. 113 (9): p. 1222–1225.</mixed-citation><mixed-citation xml:lang="en">Ramsay C. A. Solar urticaria treatment by inducing tolerance to artificial radiation and natural light // Arch Dermatol. 1977. 113 (9): p. 1222–1225.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Black A. K., Sibbald R. G., Greaves M. W. Cold urticaria treated by induction of tolerance // Lancet. 1979. 2 (8149): p. 964.</mixed-citation><mixed-citation xml:lang="en">Black A. K., Sibbald R. G., Greaves M. W. Cold urticaria treated by induction of tolerance // Lancet. 1979. 2 (8149): p. 964.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Leigh I. M., Ramsay C. A. Localized heat urticaria treated by inducing tolerance to heat // Br J Dermatol. 1975. 92 (2): p. 191–194.</mixed-citation><mixed-citation xml:lang="en">Leigh I. M., Ramsay C. A. Localized heat urticaria treated by inducing tolerance to heat // Br J Dermatol. 1975. 92 (2): p. 191–194.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Keahey T. M., Indrisano J., Kaliner M. A. A case study on the induction of clinical tolerance in cold urticaria // J Allergy Clin Immunol. 1988. 82 (2): p. 256–261.</mixed-citation><mixed-citation xml:lang="en">Keahey T. M., Indrisano J., Kaliner M. A. A case study on the induction of clinical tolerance in cold urticaria // J Allergy Clin Immunol. 1988. 82 (2): p. 256–261.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
